SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ANG Lifesciences India informs about company updates

27 Dec 2017 Evaluate

In reference to the e-mail regarding Discrepancy in Financial Results submitted for the Half Year ended September 2017 under Reg. 33(3)(b) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 dated November 21, 2017, ANG Lifesciences India has informed about the bifurcation of Trade payables as per Schedule III of Companies Act, 2013 in Statement of Assets & Liability.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

24.26 0.02 (0.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×